Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASP5354 for Ureter Visualization in Colorectal Surgery
NCT04238481Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2020
- Primary completion
- Nov 2021
- Modality
- Light/Condition-Responsive Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of pudexacianinium chloride in colorectal diseases, sponsored by Astellas Pharma. Started Oct 2020; status: completed.
02
Drugs
pudexacianinium chloride
03
Conditions
colorectal diseases
Beyond the preview
Go deeper on NCT04238481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04238481.